Epstein Secrets

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

rms and conditions available at http://www.bankofamerica.com/emaildisclaimer. If you are not the i=tended recipient, please delete this message. Am=nda Ens Director Bank of America Merrill Lynch= Merrill Lynch, Pierce, Fenner=& Smith Incorporated One Bryant Park, 5th Floor, N=w York, NY 10036 Phone:

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

rms and conditions available at http://www.bankofamerica.com/emaildisclaimer. If you are not the i=tended recipient, please delete this message. Am=nda Ens Director Bank of America Merrill Lynch= Merrill Lynch, Pierce, Fenner=& Smith Incorporated One Bryant Park, 5th Floor, N=w York, NY 10036 Phone:

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

rms and conditions available at http://www.bankofamerica.com/emaildisclaimer. If you are not the i=tended recipient, please delete this message. Am=nda Ens Director Bank of America Merrill Lynch= Merrill Lynch, Pierce, Fenner=& Smith Incorporated One Bryant Park, 5th Floor, N=w York, NY 10036 =C2 T